Facebook
Twitter
LinkedIn
ForwardFebruary 28, 2023 - Transplants
Please note, access to symposium recordings is included with registration.
Access will be available for 30 days post event.
With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices and major updates in the biology, diagnosis, and management of hematologic malignancies.
Each 90-minute webinar will have two talks followed by 30 minutes of discussion and audience questions. Presenters will include internationally-known disease experts from Mass General Cancer Center covering practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma
Target Audience
This activity is intended for physicians, nurses, physician assistants, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Discuss practice-changing updates in the management of hematopoietic stem cell transplant
- Review important survivorship management principles after stem cell transplant
Additional Information
Massachusetts General Hospital Cancer Center & Mass General Brigham
| 5:00pm | Practice Changing Updates in Transplant |
| 5:30 | Addressing the Survivorship Care Needs of Hematopoietic Stem Cell Transplant Recipients |
| 6:00 | Q&A/Discussion |
| 6:30 | Adjourn |
Course Director
 | P. Connor Johnson, MD Hematology/Oncology, Massachusetts General Hospital Cancer Center Instructor in Medicine, Harvard Medical School |
Speakers
 | Zach DeFilipp, MD Director, BMT Clinical Research, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School |
 | Areej El-Jawahri, MD Associate Director, Cancer Outcomes Research and Education Program Director, Bone Marrow Transplant Survivorship Program, Massachusetts General Hospital Cancer Center Associate Professor of Medicine, Harvard Medical School |
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Available Credit
- 1.50 AAPA Category I CME
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Nursing Contact Hours
- 1.50 Participation
Price
CANCELLATION POLICY:
Registrations cancelled on or before February 14, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after February 14, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.